Allurion Technologies Inc (ALUR)
2.20
-0.15
(-6.38%)
USD |
NYSE |
May 02, 16:00
2.20
0.00 (0.00%)
After-Hours: 16:09
Allurion Technologies Enterprise Value: 113.06M for May 1, 2024
Enterprise Value Chart
Historical Enterprise Value Data
Date | Value |
---|---|
May 01, 2024 | 113.06M |
April 30, 2024 | 96.79M |
April 29, 2024 | 96.79M |
April 26, 2024 | 92.48M |
April 25, 2024 | 89.13M |
April 24, 2024 | 88.18M |
April 23, 2024 | 86.74M |
April 22, 2024 | 92.00M |
April 19, 2024 | 95.83M |
April 18, 2024 | 98.22M |
April 17, 2024 | 104.45M |
April 16, 2024 | 113.54M |
April 15, 2024 | 114.97M |
April 12, 2024 | 112.58M |
April 11, 2024 | 114.02M |
April 10, 2024 | 107.32M |
April 09, 2024 | 110.67M |
April 08, 2024 | 112.10M |
April 05, 2024 | 116.89M |
April 04, 2024 | 147.99M |
April 03, 2024 | 83.39M |
April 02, 2024 | 92.48M |
April 01, 2024 | 81.95M |
March 28, 2024 | 84.35M |
March 27, 2024 | 84.83M |
Date | Value |
---|---|
March 26, 2024 | 90.09M |
March 25, 2024 | 81.00M |
March 22, 2024 | 89.13M |
March 21, 2024 | 96.46M |
March 20, 2024 | 100.75M |
March 19, 2024 | 106.00M |
March 18, 2024 | 126.03M |
March 15, 2024 | 127.46M |
March 14, 2024 | 130.79M |
March 13, 2024 | 134.61M |
March 12, 2024 | 126.98M |
March 11, 2024 | 125.07M |
March 08, 2024 | 130.32M |
March 07, 2024 | 129.36M |
March 06, 2024 | 134.61M |
March 05, 2024 | 134.13M |
March 04, 2024 | 142.72M |
March 01, 2024 | 155.59M |
February 29, 2024 | 153.68M |
February 28, 2024 | 147.01M |
February 27, 2024 | 142.24M |
February 26, 2024 | 134.61M |
February 23, 2024 | 136.52M |
February 22, 2024 | 131.75M |
February 21, 2024 | 143.67M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
81.00M
Minimum
Mar 25 2024
464.01M
Maximum
Aug 02 2023
188.88M
Average
158.07M
Median
Nov 29 2023
Enterprise Value Benchmarks
Outset Medical Inc | 70.23M |
Paragon 28 Inc | 851.57M |
Perspective Therapeutics Inc | 990.24M |
Xtant Medical Holdings Inc | 128.19M |
Asensus Surgical Inc | 43.86M |
Enterprise Value Related Metrics
Net Income (Quarterly) | -19.18M |
Revenue (Quarterly) | 8.235M |
Total Expenses (Quarterly) | 33.97M |
EPS Diluted (Quarterly) | -0.40 |
Gross Profit Margin (Quarterly) | 78.08% |
Profit Margin (Quarterly) | -232.9% |
Earnings Yield | -83.04% |
Normalized Earnings Yield | -89.88 |